INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

RTTNews | vor 917 Tagen
INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

(RTTNews) - Biotechnology company INOVIO Pharmaceuticals, Inc. (INO) announced Thursday positive results from a Phase 1b clinical trial evaluating INO-4201, a DNA vaccine candidate, as a booster in healthy adult participants who previously received a single injection of Ervebo.

In the trial, INO-4201 was well-tolerated and boosted humoral responses in 100% (36 of 36) of treated participants.

INO-4201 was evaluated in a 46-participant randomized, placebo-controlled Phase 1b trial (NCT04906629) to assess its safety, tolerability, and immunogenicity in healthy adult participants who previously received a single injection of Ervebo, a vaccine approved by the U.S. Food and Drug Administration for the prevention of disease caused by Zaire ebolavirus in individuals 18 years of age and older.

The participants were dosed with 1 mg of INO-4201 injected intradermally followed by electroporation using our investigational proprietary smart device, CELLECTRA. The trial was designed to test whether INO-4201 can be used as a booster in healthy participants previously vaccinated with Ervebo.

For More Such Health News, visit rttnews.com

read more
Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that data from its completed Phase 1/2 trial of INO-3107 for the treatment of RRP could support INOVIO's submission of a BLA for review under the FDA's accelerated approval program.
RTTNews | vor 667 Tagen
Sensex, Nifty Set To Open Lower On Trade Concerns

Sensex, Nifty Set To Open Lower On Trade Concerns

Indian shares look set to open on a sluggish note Friday as U.S. President has ruled out any possibility of trade negotiations with India and Prime Minister Narendra Modi said India would not compromise on the interests of its farmers, fishermen or livestock rearers, even if it meant paying "a heavy personal price."
RTTNews | vor 35 Minuten
Thai Stock Market May Spin Its Wheels On Friday

Thai Stock Market May Spin Its Wheels On Friday

The Thai stock market has moved higher in four straight sessions, gathering almost 50 points or 4.1 percent along the way. The Stock Exchange of Thailand now sits just above the 1,265-point plateau although it may be stuck in neutral on Friday.
RTTNews | vor 1Std 9 Minuten
Continued Consolidation Called For Indonesia Stock Market

Continued Consolidation Called For Indonesia Stock Market

The Indonesia stock market has finished lower in back-to-back sessions, slipping more than 25 points or 0.3 percent in that span. The Jakarta Composite Index now sits just above the 7,490-point plateau and it may take further damage on Friday.
RTTNews | vor 1Std 39 Minuten
Japanese Market Sharply Higher; Up 2%

Japanese Market Sharply Higher; Up 2%

Extending the gains in the previous three sessions, the Japanese market is sharply higher on Friday, following the mixed cues from Wall Street overnight. The Nikkei 225 is jumping almost 2 percent to above the 41,850 level, with gains across all sectors led by index heavyweights, exporters and technology stocks.
RTTNews | vor 1Std 42 Minuten